KACL,Kairous Acquisition Corp. Limited | Financials

Financials

KACL

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Kairous Acquisition Corp. LimitedKACL

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Kairous Acquisition Corp. Limited does not have significant operations.

It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

The company intends to focus on opportunities in Asia, excluding China. Kairous Acquisition Corp. Limited was incorporated in 2021 and is based in Kuala Lumpur, Malaysia.

Latest News >

Ford Delays Electric SUV Launch, Plans Hybrid Output Ramp

Apr 4, 2024

12:59 PM EDT, 04/04/2024 (MT Newswires) -- Ford Motor ( F ) pushed back the timeline of planned electric sports utility vehicle deliveries while saying that it planned to ramp hybrid output, moves the automaker said should help it more profitably scale its EV business and meet customer demand. An overhaul of Ford's Ontario, Canada, plant into an EV manufacturing...

US Equity Indexes Higher After Weekly Jobless Claims Rise to Highest Since January

Apr 4, 2024

01:10 PM EDT, 04/04/2024 (MT Newswires) -- US benchmark stock indexes rose broadly after weekly initial jobless claims increased more than forecast ahead of nonfarm payrolls due Friday. The S&P 500 climbed 0.8% to 5,253.1, the Nasdaq Composite was up 1.1% at 16,462.3 and the Dow Jones Industrial Average was 0.5% higher at 39,310.4 after midday on Thursday. All sectors...

Aduro Clean Technologies Provides Update On Joint Western University Research Project

Apr 4, 2024

12:50 PM EDT, 04/04/2024 (MT Newswires) -- Aduro Clean Technologies ( ACTHF ) , a Canadian technology company, provided an update Thursday on its research project titled Tuning Supercritical Fluids for Polymer Recycling to Monomers and Chemicals in partnership with Ontario's Western University. Launched in early 2023 with a C$1.15 million in grant funding from the NSERC Alliance and Mitacs...

Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars

Apr 4, 2024

Thursday, the FDA granted 510(k) clearance to AngioDynamics Inc’s AlphaVac F1885 System for pulmonary embolism (PE). The expanded FDA indication allows for the utilization of the AlphaVac F1885 System for PE, which broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature. The indication expands treatment options for patients with PE, reducing thrombus...